H2020 FET-Open: “Intelligent Breast Cancer Diagnosis and Monitoring Therapeutic Response (INBRECAN)

PEER Award Holder: Dr Hadi Heidari, University of Glasgow)

Breast Cancer is the most common cancer in the WHO Europe region women with an estimated incidence of 404,920 corresponding to 1 in 8 women in the EU-28 will develop Breast Cancer before the age of 85. An average of 20% of Breast Cancer cases in Europe occur in women when they are younger than 50 years old; 36% occur at age 50–64. Estimated number of women who died from Breast Cancer in 2018: WHO Europe region: 150,700 (gco.iarc.fr/today). The absence of an applicable early diagnostic tool in Breast Cancer is the driving force for finding novel and ambitious alternatives. In this regard, the aim of the project will be:

  1. Improved awareness of Breast Cancer as an endemic disease in Europe, its causes, and its early detection and diagnosis options, which presents potential benefit both in terms of the health of female European population and the European economy, which is overburdened by associated healthcare costs.

  2. Increased attention on the multidisciplinary education and training of researchers for Breast Cancer advanced tools and issue, which provides the basis for targeted advances in the field for coming decades.

  3. Increased industrial focus on Breast Cancer point-of-care diagnostics development, which may lead to novel and effective Breast Cancer diagnose and therapy responses in both the short- and long-term.

  4. Improved and advanced knowledge about early detection of BC from sensory data introduced by novel methods and experiments, transferred through publications, media and networking.

This programme is designed to make a substantial contribution to the future diagnosis of breast cancer through innovative gas sensors (e-nose) and artificial intelligence. This project will strengthen the Scotland/EU innovation capacity by exploring unique ideas on biomaterials, biosensors, bioelectronics, and clinic research for intelligent breast cancer diagnoses and monitoring the treatment response. This project will provide a cohort of exceptional skills within Scotland/EU which will contribute to addressing the problem of “Intelligent Breast Cancer Diagnosis and Monitoring Therapeutic Response”. Additionally, this will contribute greatly to future collaboration of this project by creating new and improved trans-national collaborative links between the participants leading to strong future research collaborations across all participants of the network and, in the longer term, with them in their future careers. The strong involvement from across the public and private sectors, academic and non-academic participants will strengthen existing partnerships, and lead to the development of new, exciting long-term collaborations.


SRPe